Inge Grondman
Impact in
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- COVID-19 Clinical Research Studies 8
-
- Sepsis Diagnosis and Treatment 7
- Adipokines, Inflammation, and Metabolic Diseases 2
- Co-authors
- Mihai G. Netea (15 shared papers)Peter Pickkers (8 shared papers)Matthijs Kox (8 shared papers)Nico Janssen (8 shared papers)Aline de Nooijer (7 shared papers)Frank L. van de Veerdonk (8 shared papers)Mihai Ioana (2 shared papers)Anca Lelia Riza (2 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Bioscience Reports (1 paper)Journal of Leukocyte Biology (1 paper)Nature Communications (1 paper)Cell Reports (1 paper)
- Partner nations
- NetherlandsGermanyRomania
In The Last Decade
Inge Grondman
16 papers receiving 481 citations
Peers
Comparison fields: 5 of 87
- Infectious Diseases 213
- Critical Care and Intensive Care Medicine 56
- Neurology 108
- Immunology 146
- Internal Medicine 20
Countries citing papers authored by Inge Grondman
This map shows the geographic impact of Inge Grondman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Grondman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Grondman more than expected).
Fields of papers citing papers by Inge Grondman
This network shows the impact of papers produced by Inge Grondman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Grondman. The network helps show where Inge Grondman may publish in the future.
Co-authors
The 25 scholars most cited alongside Inge Grondman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 102 | |
| 2 | 2020 | 95 | |
| 3 | 2020 | 89 | |
| 4 | 2019 | 35 | |
| 5 | 2023 | 28 | |
| 6 | 2021 | 27 | |
| 7 | 2021 | 25 | |
| 8 | 2021 | 17 | |
| 9 | 2022 | 15 | |
| 10 | 2022 | 13 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 8 | |
| 13 | 2022 | 8 | |
| 14 | 2025 | 7 | |
| 15 | 2022 | 6 | |
| 16 | 2024 | 3 |
About Inge Grondman
Inge Grondman is a scholar working on Infectious Diseases, Epidemiology, Immunology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 486 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Sepsis Diagnosis and Treatment (7 papers), Inflammation biomarkers and pathways (3 papers), Immune Response and Inflammation (3 papers), Long-Term Effects of COVID-19 (2 papers), Thermal Regulation in Medicine (2 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers) and Immune cells in cancer (2 papers). The work is most often cited by research in Infectious Diseases (213 citations), Critical Care and Intensive Care Medicine (56 citations), Neurology (108 citations), Immunology (146 citations) and Internal Medicine (20 citations). Inge Grondman has collaborated with scholars based in Netherlands, Germany and Romania. Frequent co-authors include Mihai G. Netea, Peter Pickkers, Matthijs Kox, Nico Janssen, Aline de Nooijer, Frank L. van de Veerdonk, Mihai Ioana, Anca Lelia Riza, Leo A. B. Joosten and Emma J. Kooistra. Their work appears in journals such as Frontiers in Immunology, Bioscience Reports, Journal of Leukocyte Biology, Nature Communications and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.